Phase 2 Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to follow the trial's treatment plan, attend all scheduled visits, complete required tests, and sign a consent form agreeing to take part
- You are 18 years old or older (any gender)
- You are generally well enough to carry out light activity and care for yourself, based on a standard fitness scale used in cancer research (confirm with trial site)
- Your doctor expects you to live for at least 12 weeks
- You have at least one tumour that can be measured using standard medical scans
- If you are able to have children (male or female), you are willing to use highly effective birth control from the time you sign the consent form until at least 6 months after your last dose of the trial drug
Who may not be able to join:
- You received a live vaccine in the 4 weeks before starting the trial, or plan to receive one during the trial or within 4 weeks of finishing it
- You had major surgery or a significant medical procedure or test within the 4 weeks before starting the trial
- You have an active autoimmune disease, or have had one in the past that could come back (confirm with trial site)
- You have a history of serious heart or stroke-related conditions
- You currently have an active infection
- You have a history of significant mental illness that could affect your ability to understand or consent, or a history of substance abuse or addiction
- You are currently pregnant or breastfeeding
- The trial doctor feels there are other reasons that make participation unsuitable for you (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yu Chen, Fujian Cancer Hospital
Phone: 025-83378099
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Occurrence of adverse event (AE) and serious adverse event (SAE); Objective Response Rate (ORR); Progression-free Survival(PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.